sellWeak cluster of 210b5-1 plan
BENKOWITZ MICHAEL sold $3.6M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $364.62, traded Jan 13, 2025, filed Jan 14, 2025.
Warning score
38Value
$3.6M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-25-000356, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 13, 2025 | MOption exercise Common Stockindirect: By Trust10b5-1 | +7,500 | $111.00 | $833k | 7,500 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -196 | $360.85 | $71k | 7,304 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -604 | $361.95 | $219k | 6,700 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,668 | $362.67 | $605k | 5,032 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,300 | $363.80 | $473k | 3,732 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -800 | $364.90 | $292k | 2,932 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -900 | $365.79 | $329k | 2,032 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,432 | $366.87 | $525k | 600 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -600 | $367.89 | $221k | 0 | Jan 14, 2025 |
| Jan 13, 2025 | MOption exercise Common Stockindirect: By Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -775 | $362.58 | $281k | 1,725 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -600 | $364.06 | $218k | 1,125 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -425 | $365.58 | $155k | 700 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -600 | $366.98 | $220k | 100 | Jan 14, 2025 |
| Jan 13, 2025 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $367.99 | $37k | 0 | Jan 14, 2025 |
| Jan 13, 2025 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -7,500 | $0.00 | $0 | 52,179 | Jan 14, 2025 |
| Jan 13, 2025 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -2,500 | $0.00 | $0 | 19,500 | Jan 14, 2025 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $640k | 2,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.0M | 9,679 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.